KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Change in Account Payables (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Change in Account Payables for 17 consecutive years, with -$90.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 117.41% to -$90.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.0 million, a 101.09% decrease, with the full-year FY2025 number at -$2.0 million, down 101.09% from a year prior.
  • Change in Account Payables was -$90.0 million for Q4 2025 at Bristol Myers Squibb, down from $160.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $517.0 million in Q4 2024 to a low of -$374.0 million in Q3 2024.
  • A 5-year average of $36.7 million and a median of -$3.0 million in 2022 define the central range for Change in Account Payables.
  • Biggest YoY gain for Change in Account Payables was 713.04% in 2023; the steepest drop was 768.42% in 2023.
  • Bristol Myers Squibb's Change in Account Payables stood at $226.0 million in 2021, then skyrocketed by 79.2% to $405.0 million in 2022, then rose by 9.63% to $444.0 million in 2023, then grew by 16.44% to $517.0 million in 2024, then plummeted by 117.41% to -$90.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Change in Account Payables are -$90.0 million (Q4 2025), $160.0 million (Q3 2025), and $13.0 million (Q2 2025).